12. December 2011 16:03
A drug used to treat breast cancer in post-menopausal women – Letrozol, has been banned by the Government of India because its use as a fertility drug is believed to have resulted in babies with bone malformations and other complications.
The Government of India has banned the manufacture, sale and distribution of Letrozol, a drug meant for treating breast cancer in post-menopausal women. The drug had become controversial because it was being used to treat infertility in women unable to ovulate, i.e., these women were unable to produce the ovum or the reproductive cell that divides and forms into an embryo after fertilization by the spermatozoa. When it was discovered that babies born to mothers using Letrozol to treat infertility had bone malformations and other complications, the government stepped in to ban the drug in the public interest, taking recourse to the powers conferred on it by the Drugs and Cosmetic Act, 1940. The government was satisfied that safer alternatives to the drug were available, according to a Ministry of Health and Welfare press release.
SOURCE: FIRST POST